SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000891293-17-000089
Filing Date
2017-08-04
Accepted
2017-08-03 19:38:36
Documents
53
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cti10q06302017.htm 10-Q 1007931
2 EXHIBIT 3.8 ex38-articlesamendment.htm EX-3.8 12139
3 EXHIBIT 10.3 ex103-offerletter.htm EX-10.3 11748
4 EXHIBIT 15 ex15-auditorawarenessletter.htm EX-15 4422
5 EXHIBIT 31.1 ex311-cti10q06302017.htm EX-31.1 11005
6 EXHIBIT 31.2 ex312-cti10q06302017.htm EX-31.2 12149
7 EXHIBIT 32 ex32-cti10q06302017.htm EX-32 11910
  Complete submission text file 0000891293-17-000089.txt   3653603

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT ctic-20170630.xml EX-101.INS 480961
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ctic-20170630.xsd EX-101.SCH 27854
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ctic-20170630_cal.xml EX-101.CAL 65561
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ctic-20170630_def.xml EX-101.DEF 118329
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ctic-20170630_lab.xml EX-101.LAB 398415
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ctic-20170630_pre.xml EX-101.PRE 232667
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-28386 | Film No.: 171006581
SIC: 2834 Pharmaceutical Preparations